⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5334234 | 0.94 | — | — | |
| Hydrogen Sulfide SCHEMBL28451021 | 0.94 | — | — | |
| Bromide SCHEMBL28927015 | 0.94 | — | — | |
| SCHEMBL2350935 | 0.86 | ESR2 (0.52) | — | |
| Boric Acid SCHEMBL28033106 | 0.86 | ESR2 (0.52) | — | |
| Ethylamine SCHEMBL5009539 | 0.84 | ESR2 (0.45) | — | |
| SCHEMBL28685012 | 0.82 | ESR2 (0.44) | — | |
| Acetic Acid SCHEMBL11041891 | 0.82 | HSD17B1 (0.53) | — | |
| Formic Acid SCHEMBL28050270 | 0.82 | ESR2 (0.48) | — | |
| SCHEMBL20550243 | 0.80 | ESR2 (0.61) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105452220-A | Sulfamoyl pyrrole amide derivative and application thereof as medicine for treating hepatitis B | JANSSEN R&D IRELAND | 2016-03-30 | — | — | CN | disclosed |
| CN-102516204-B | The morpholine replaced and thiomorpholine derivatives | H. LUNDHECK A/S (DK) | 2016-01-20 | — | — | CN | disclosed |
| CN-105189453-A | Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis b | JANSSEN R & D IRELAND | 2015-12-23 | — | — | CN | disclosed |
| CN-105102451-A | N-phenyl-carboxamide derivatives and their use as medicaments for the treatment of hepatitis b | JANSSEN R & D IRELAND | 2015-11-25 | — | — | CN | disclosed |
| CN-104902885-A | Sulfamoyl-arylamides and their use as medicaments for the treatment of hepatitis B | JANSSEN R & D IRELAND | 2015-09-09 | — | — | CN | disclosed |
| CN-104812743-A | Sulfamoyl-arylamides and their use as medicaments for the treatment of hepatitis B | JANSSEN SCIENCES IRELAND UC IE | 2015-07-29 | — | — | CN | disclosed |
| CN-102471328-B | Pyridin-4-yl derivatives | ACTELION PHARMACEUTICALS LTD | 2015-04-01 | — | — | CN | disclosed |
| CN-101663347-A | Solvent-soluble 6, 6-polyimide copolymer and process for producing the same | SOLPIT IND LTD | 2010-03-03 | — | — | CN | disclosed |
| EP-1940781-A1 | PHENYL-ACETAMIDE NNRT INHIBITORS | F.HOFFMANN-LA ROCHE AG (CH) | 2008-07-09 | — | — | EP | disclosed |
| US-7388111-B2 | Non-nucleoside reverse transcriptase inhibitors | ROCHE PALO ALTO LLC (US) | 2008-06-17 | — | — | US | disclosed |
| CN-101035802-A | Inhibitors of IAP | GENENTECH INC (US) | 2007-09-12 | — | — | CN | disclosed |
| WO-2007045573-A1 | PHENYL-ACETAMIDE NNRT INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2007-04-26 | — | — | WO | disclosed |
| US-20070088053-A1 | Non-nucleoside reverse transcriptase inhibitors | ROCHE PALO ALTO LLC | 2007-04-19 | — | — | US | disclosed |